Logo image of EOS.PA

ACTEOS (EOS.PA) Stock Fundamental Analysis

EPA:EOS - Euronext Paris - Matif - FR0000076861 - Common Stock - Currency: EUR

1.0302  -0.04 (-3.67%)

Fundamental Rating

1

EOS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 94 industry peers in the Software industry. Both the profitability and financial health of EOS have multiple concerns. EOS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EOS has reported negative net income.
In the past year EOS had a positive cash flow from operations.
EOS had negative earnings in 4 of the past 5 years.
Of the past 5 years EOS 4 years had a positive operating cash flow.
EOS.PA Yearly Net Income VS EBIT VS OCF VS FCFEOS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

With a Return On Assets value of -12.44%, EOS is not doing good in the industry: 71.28% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -12.44%
ROE N/A
ROIC N/A
ROA(3y)-4.8%
ROA(5y)-3.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EOS.PA Yearly ROA, ROE, ROICEOS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

With a Gross Margin value of 35.34%, EOS is not doing good in the industry: 74.47% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EOS has declined.
EOS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
EOS.PA Yearly Profit, Operating, Gross MarginsEOS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

EOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EOS has been reduced compared to 1 year ago.
The number of shares outstanding for EOS remains at a similar level compared to 5 years ago.
Compared to 1 year ago, EOS has a worse debt to assets ratio.
EOS.PA Yearly Shares OutstandingEOS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
EOS.PA Yearly Total Debt VS Total AssetsEOS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 0.38, we must say that EOS is in the distress zone and has some risk of bankruptcy.
EOS has a worse Altman-Z score (0.38) than 74.47% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC7.78%
EOS.PA Yearly LT Debt VS Equity VS FCFEOS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

EOS has a Current Ratio of 0.81. This is a bad value and indicates that EOS is not financially healthy enough and could expect problems in meeting its short term obligations.
EOS has a worse Current ratio (0.81) than 76.60% of its industry peers.
A Quick Ratio of 0.80 indicates that EOS may have some problems paying its short term obligations.
With a Quick ratio value of 0.80, EOS is not doing good in the industry: 74.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.8
EOS.PA Yearly Current Assets VS Current LiabilitesEOS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

EOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1317.84%.
Looking at the last year, EOS shows a very negative growth in Revenue. The Revenue has decreased by -10.31% in the last year.
Measured over the past years, EOS shows a decrease in Revenue. The Revenue has been decreasing by -1.69% on average per year.
EPS 1Y (TTM)-1317.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-414.19%
Revenue 1Y (TTM)-10.31%
Revenue growth 3Y0.21%
Revenue growth 5Y-1.69%
Sales Q2Q%-25.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EOS.PA Yearly Revenue VS EstimatesEOS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EOS.PA Yearly EPS VS EstimatesEOS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 0 0 0.01 0.01

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EOS.PA Price Earnings VS Forward Price EarningsEOS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

90.43% of the companies in the same industry are more expensive than EOS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.51
EOS.PA Per share dataEOS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EOS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACTEOS

EPA:EOS (4/24/2025, 7:00:00 PM)

1.0302

-0.04 (-3.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.45M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF 2.73
P/B N/A
P/tB N/A
EV/EBITDA 6.51
EPS(TTM)-0.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.38
OCFY36.58%
SpS3.89
BVpS-0.58
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.34%
FCFM N/A
ROA(3y)-4.8%
ROA(5y)-3.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score4
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 3.18
Cap/Depr 117.57%
Cap/Sales 13.79%
Interest Coverage N/A
Cash Conversion 142.11%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.8
Altman-Z 0.38
F-Score4
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)120.97%
Cap/Depr(5y)100.16%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1317.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-414.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.31%
Revenue growth 3Y0.21%
Revenue growth 5Y-1.69%
Sales Q2Q%-25.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-195.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y293.15%
OCF growth 3Y-17.91%
OCF growth 5YN/A